Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
Do computerized mole-mapping tools play a role in your clinical practice?
Are they effective adjuncts in diagnosing atypical pigmented lesions?
Related Questions
What patient characteristics or clinical scenarios guide the decision in performing slow Mohs procedures?
Are there certain patient characteristics that drive you to recommend intralesional 5-FU or MTX for a large SCC on the back?
Have you considered intralesional cempilumab for locally advanced NMSC/KCs prior to surgery?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
What chemoprophylaxis, if any, would you consider in a transplant patient with numerous KC/NMSCs?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
What is your preferred treatment for actinic cheilitis?
What biopsy/surgical approach do you take for multiple BAPoma lesions in a patient with BAP1 tumor predisposition syndrome?
What is the recommended approach for systemic therapy in a patient with metastatic cutaneous squamous cell carcinoma with active autoimmune disease (dermatomyositis)?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?